Clinical trial
Efficacy of Galantamine to Treat Schizophrenia
NCT00232349 · Seattle Institute for Biomedical and Clinical Research, Other · Terminated
Key facts
| NCT number | NCT00232349 |
|---|---|
| Title | Efficacy of Galantamine to Treat Schizophrenia |
| Official title | An Open-Label Trial of Adjunctive Galantamine Maintenance Therapy to Treat Functional Impairments in Chronic Outpatients With Schizophrenia |
| Lead sponsor | Seattle Institute for Biomedical and Clinical Research, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorder |
| Intervention type | Drug |
| Interventions | galantamine |
| Enrollment | 21 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Oct 4, 2005 |
| Last update posted | Jul 31, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: